Claire Quinn (GMT time zone) Corporate Communications, ICON plc [email protected] +353 87 4066091 Weber Shandwick (PR adviser) Lisa Henry (GMT time zone) +447785 458203 lhenry ...

A month has gone by since the last earnings report for Icon PLC (ICLR). Shares have lost about 8.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

ICON Misses on Q3 Earnings, Lowers 2024 Guidance ICON plc delivered third-quarter 2024 adjusted earnings per share of $3.35, up 1.5% from the year-ago period’s figure. However, the metric missed ...

ICON plc, (NASDAQ: ICLR) a world ... engineers and domain experts, is responsible for developing and deploying AI solutions that accelerate trials, enhance data and optimise operational efficiencies.

DUBLIN - ICON plc (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, has announced the appointment of Nigel ...

Icon PLC expects full-year earnings in the range of $12.75 to $14.25 per share, with revenue in the range of $7.75 billion to $8.15 billion. _____ This story was generated by Automated Insights ...

ICON plc, a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Leerink Partners Global ...

More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain ...

A month has gone by since the last earnings report for Icon PLC (ICLR). Shares have lost about 8.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portf ...

DUBLIN - ICON plc (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, has announced the appointment of Nigel ...